Abstract
Ibuprofen (IBU) is a non-steroidal anti-inflammatory drug exhibiting optical isomerism. Only the racemate is in clincal use. Inin vitro studies it has been demonstrated that only the S(+)-enantiomer inhibits the PG synthetase system. Nevertheless, it is widely believed that the sole use of the active isomer does not comprise any advantages since the inactive isomer is converted within the human body. In a triple cross-over study (300 mg S(+), 300 mg R(−), 600 mg racemic IBU;n=8), we could show that the converted R(−)-IBU after racemate administration provides for only one third of the AUC of S(+)-IBU obtained after S(+)-application. Highest S(+)-peak plasma levels were reached after S(+)-IBU, lower ones after racemate. We, therefore, studied 4 patients with classical rheumatoid arthritis treated with 2–3 doses of 500 mg of S(+)-IBU/day over a two week period. Significant clinical recovery (Ritchie-indexp<0.01; analogue scale painp<0.05, motionp<0.01) was reached after one week. The results indicate that a reduction of dose and of metabolic load is possible if the S(+)-enantiomer is administrated.
References
P. Jenner, B. Testa, Drug Metab. Rev.2, 117–184 (1974).
S. S. Adams, P. Bresloff and C. G. Mason,Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (−)-isomer. J. Pharm. Pharmac.28, 256 (1976).
K. Brune, U. Aehringhaus and B. A. Peskar,Pharmacological control of leukotriene and prostaglandin production from mouse peritoneal macrophages. Agents and Actions14, 729–734 (1984).
K. Brune, K. D. Rainsford, K. Wagner and B. A. Peskar,Inhibition by anti-inflammatory drugs of prostaglandin production in cultured macrophages. Factors influencing the apparent drug effects. Naunyn-Schmiedebergs Arch. Pharmac.315, 269 (1981).
G. Geisslinger, K. Dietzel, D. Loew, O. Schuster, G. Rau, G. Lachmann and K. Brune,High performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids. J. Chromato. (in press, 1989).
G. Heinzel,TOPFIT InDrug development and evaluation, vol. 6 (Eds. G. Bozler and J. M. van Rossum). Fischer Verlag, Stuttgart, New York 1982.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Geisslinger, G., Stock, K.P., Bach, G.L. et al. Pharmacological differences between R(−)-and S(+)-ibuprofen. Agents and Actions 27, 455–457 (1989). https://doi.org/10.1007/BF01972851
Issue Date:
DOI: https://doi.org/10.1007/BF01972851